Bottom line
How much do DLHIX and SCHLX overlap?
44% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 38.8% of DLHIX's assets and 47.2% of SCHLX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings DLHIX and SCHLX have in common
| Holding | % of DLHIX | % of SCHLX | Overlap |
|---|---|---|---|
| Abbvie Inc ABBV | 4.19% | 4.90% | 4.19% |
| Eli Lilly & Company LLY | 4.16% | 13.85% | 4.16% |
| Regeneron Pharmaceuticals Inc REGN | 3.91% | 1.43% | 1.43% |
| Unitedhealth Group Inc UNH | 3.88% | 5.73% | 3.88% |
| Pfizer Inc PFE | 3.84% | 1.17% | 1.17% |
| Merck & Company Inc MRK | 3.68% | 4.85% | 3.68% |
| Gilead Sciences Inc GILD | 3.54% | 2.78% | 2.78% |
| Astrazeneca Plc AZN | 3.27% | 3.80% | 3.27% |
| Roche Holding Ag ROP | 3.01% | 1.24% | 1.24% |
| Amgen Inc AMGN | 2.27% | 2.88% | 2.27% |
| Vertex Pharmaceuticals Inc VRTX | 1.66% | 2.45% | 1.66% |
| Boston Scientific Corp BSX | 1.42% | 2.10% | 1.42% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in DLHIX
- Ucb Sa — 5.19%
- Elevance Health Inc — 3.25%
- Chugai Pharmaceutical Co Ltd — 2.77%
- Viatris Inc — 2.48%
- Oruka Therapeutics Inc — 2.41%
- Halozyme Therapeutics Inc — 2.30%
- Illumina Inc — 2.11%
- Alkermes Plc — 1.82%
- Viking Therapeutics Inc — 1.72%
- Roivant Sciences Ltd — 1.60%
- Neurocrine Biosciences Inc — 1.57%
- Arcus Biosciences Inc — 1.56%
- Zimmer Biomet Holdings Inc — 1.42%
Only in SCHLX
- Johnson & Johnson — 6.19%
- Thermo Fisher Scientific Inc — 3.46%
- Novartis AG — 2.90%
- Intuitive Surgical Inc — 2.69%
- Stryker Corp — 2.61%
- Abbott Laboratories — 2.39%
- Danaher Corp — 2.13%
- McKesson Corp — 2.05%
- Novo Nordisk A/S — 1.73%
- Medtronic PLC — 1.54%
- Bristol-Myers Squibb Co — 1.50%
- Cardinal Health Inc — 1.34%
- Cencora Inc — 1.26%
Asset mix
| Asset type | DLHIX | SCHLX |
|---|---|---|
| Stocks | 94.8% | 99.6% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 2.0% | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | DLHIX | SCHLX |
|---|---|---|
| US | 75.4% | 85.7% |
| CH | 3.0% | 5.2% |
| BE | 5.2% | — |
| GB | 3.3% | 3.8% |
| IE | 3.2% | 1.5% |
| JP | 2.8% | — |
| FR | 2.0% | 1.0% |
| DK | — | 1.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do DLHIX and SCHLX overlap?
What stocks do DLHIX and SCHLX have in common?
Should I own both DLHIX and SCHLX?
Which holds more stocks, DLHIX or SCHLX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.